|
|
|
|
| LEADER |
00000nab a2200000 a 4500 |
| 001 |
vtls000871112 |
| 003 |
SK-MaSNL |
| 005 |
20260304125635.0 |
| 008 |
250429c2004 xo 0 slo |
| 015 |
|
|
|a SNBRB2004/05-14385
|
| 035 |
|
|
|a CLN000222664
|
| 035 |
|
|
|a urn:nbn:sk:snk-ab6zal
|
| 035 |
|
|
|a (uuid)4a22938a-f0e5-4b2e-94d0-6ca58f07fa01
|
| 035 |
|
|
|a (urnnbn)urn:nbn:sk:snk:ar-a06cal
|
| 035 |
|
|
|a (sysno)vtls000871112
|
| 040 |
|
|
|a SNKBUCL
|b slo
|c SNKBUCL
|e AACR2
|
| 041 |
0 |
|
|a eng
|
| 044 |
|
|
|a xo
|c SK
|
| 080 |
|
|
|a 616.155.392-085
|2 1997
|
| 100 |
1 |
|
|a Dědič, Karel,
|d 1958-
|4 aut
|9 27391
|
| 245 |
1 |
0 |
|a Effect of 2-chlorodeoxyadenosine therapy on bone marrow fibrosis in hairy cell leukemia
|c Karel Dědič, P. Žák
|
| 300 |
|
|
|b Tab.
|
| 504 |
|
|
|a Res. angl.
|
| 504 |
|
|
|a Bibliogr. odkazy
|
| 650 |
0 |
7 |
|a deoxyadenozíny
|x aplikácia a dávkovanie
|x použitie terapeutické
|2 MESH
|9 1438781
|
| 650 |
0 |
7 |
|a myelofibróza
|x diagnostika
|x terapia
|2 MESH
|9 1438782
|
| 650 |
0 |
7 |
|a remisia spontánna
|2 MESH
|9 1055353
|
| 650 |
0 |
7 |
|a choroby kostnej drene
|x diagnostika
|x terapia
|2 MESH
|9 1438783
|
| 650 |
0 |
7 |
|a leukémia vlasatých buniek
|2 MESH
|9 256314
|
| 655 |
|
7 |
|a články z novín a časopisov
|2 snkbucl
|9 267496
|
| 700 |
1 |
|
|a Žák, P.
|4 aut
|9 792822
|
| 773 |
0 |
|
|t Neoplasma
|g Vol. 51, no. 1 (2004), p. 56-58
|x 0028-2685
|
| 850 |
|
|
|a Slovenská národná knižnica
|
| 852 |
|
|
|a Slovenská národná knižnica
|
| 958 |
|
|
|a article27
|
| 958 |
|
|
|a NB
|
| 958 |
|
|
|a MI
|
| 958 |
|
|
|a OND
|
| 958 |
|
|
|a EUIPO
|
| 992 |
|
|
|a RBX
|
| 999 |
|
|
|c 2894449
|d 2896379
|
